Key result
A higher power shorter duration CLOSE protocol for pulmonary vein isolation reduced procedure time compared to standard CLOSE, with similar 6-month freedom from AF/AT.
Why the study?
The study was designed to compare the safety and efficacy of a conventional CLOSE protocol versus a higher power shorter duration (HPSD)-CLOSE strategy for pulmonary vein isolation in atrial fibrillation.
Does a higher power shorter duration CLOSE protocol reduce procedure time without compromising safety or efficacy compared to a standard CLOSE protocol in patients undergoing pulmonary vein isolation for atrial fibrillation?
Cohort (n=174)
Does a higher power shorter duration CLOSE protocol reduce procedure time without compromising safety or efficacy compared to a standard CLOSE protocol in patients undergoing pulmonary vein isolation for atrial fibrillation?
A higher-power short duration CLOSE protocol for pulmonary vein isolation significantly reduces procedure and ablation times while maintaining comparable safety and 6-month efficacy to the standard protocol.
Answers are grounded in this paper and cite their sources.
High-power shorter-duration CLOSE may shorten PVI time; leaves open durability of AF freedom pending randomized confirmation.
INTRODUCTION: The CLOSE protocol combines ablation index (AI) and ≤6 mm interlesion distance using standard power settings for the treatment of atrial fibrillation (AF). The purpose was to compare the safety and efficacy of a conventional CLOSE and a higher power shorter duration (HPSD)-CLOSE pulmonary vein isolation (PVI) strategy. METHODS AND RESULTS: All consecutive patients referred for PVI were included after informed consent was obtained from them. Group 1 was treated with a standard CLOSE protocol and group 2 with a HPSD-CLOSE protocol (45 W anterior and 35 W posterior). Procedural parameters and 6-month follow-up were analyzed. In total, 174 patients (group 1: n = 94 [paroxysmal: n = 74]; group 2: n = 80 [paroxysmal: n = 65], similar baseline characteristics) were included. PVI was reached in all, but procedure duration (82 ± 18 minutes vs 100 ± 22 minutes; P < .0001) and radiofrequency (RF) time (23 ± 5 minutes vs 36 ± 11 minutes; P < .0001) was shorter in group 2. First pass isolation was similar in groups 2 and 1 (left veins: 94% vs 90%; P = .42 and right veins: 83% vs 84%; P = .79, respectively). Six-month off- antiarrhythmic drugs freedom of AF/AT was similar in groups 2 and 1 (82% [paroxysmal: 86%] vs 83% [paroxysmal: 88%]; P = .93, respectively). Major complications were similar (group 2: 1% vs group 1: 3%; P = .39). CONCLUSION: A higher-power short duration approach can shorten a CLOSE procedure and reduce ablation time without having a negative impact on safety or efficiency.
No takes yet. Share an insight, caveat, or question.
Berte et al. (2019) conducted a cohort in Atrial fibrillation (n=174). Higher power shorter duration (HPSD)-CLOSE protocol vs. Standard CLOSE protocol was evaluated on 6-month off-antiarrhythmic drugs freedom of AF/AT (p=.93). A higher power shorter duration CLOSE protocol for pulmonary vein isolation reduced procedure time compared to standard CLOSE, with similar 6-month freedom from AF/AT.
Synapse has enriched 10 related papers. Consider them for comparative context: